Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07802561Phase 4Recruiting
A Phase 4 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by Nishtar Medical University. Started Apr 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07802561.